Literature DB >> 10937834

PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum.

I C Le Poole1, R E Boissy, R Sarangarajan, J Chen, J J Forristal, P Sheth, W Westerhof, G Babcock, P K Das, C B Saelinger.   

Abstract

Vitiligo is an enigmatic pigmentary disorder of the skin. Factors potentially involved in the progressive loss of melanocytes from the basal layer of the epidermis include genetically determined aberrancies of the vitiligo melanocyte. It follows that analysis of melanocytes cultured from vitiligo donors can contribute to a further understanding of the etiopathomechanism. A setback for vitiligo research has been the limited availability of vitiligo-derived melanocytes. To overcome this limitation, we have generated a vitiligo melanocyte cell line according to a protocol established previously for the immortalization of normal human melanocytes. Vitiligo melanocytes Ma9308P4 were transfected with HPV16 E6 and E7 genes using the retroviral construct LXSN16E6E7. Successful transformants were selected using geneticin and subsequently cloned to ensure genetic homogeneity. The resulting cell line PIG3V has undergone more than 100 cell population doublings since its establishment as a confluent primary culture, whereas untransfected melanocytes derived from adult skin senesce after a maximum of 50 population doublings. Cells immortalized by this transfection procedure retain lineage-specific characteristics and proliferate significantly faster than parental cells. In this study, the phenotype of PIG3V resembled melanocytes rather than melanoma cells in culture. Tyrosinase was processed properly and melanosomes remained pigmented. Importantly, ultrastructural characterization of PIG3V cells revealed dilated endoplasmic reticulum profiles characteristic of vitiligo melanocytes. An explanation for this dilation may be found in the retention of proteins with molecular weight of 37.5. 47.5, and 56.5 kDa, as determined by gel electrophoresis of microsomal proteins isolated from radiolabeled cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10937834     DOI: 10.1290/1071-2690(2000)036<0309:PAIHVM>2.0.CO;2

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  30 in total

1.  Quality control in the secretory pathway: the role of calreticulin, calnexin and BiP in the retention of glycoproteins with C-terminal truncations.

Authors:  J X Zhang; I Braakman; K E Matlack; A Helenius
Journal:  Mol Biol Cell       Date:  1997-10       Impact factor: 4.138

Review 2.  Frontiers in mammalian cell culture.

Authors:  W L McKeehan; D Barnes; L Reid; E Stanbridge; H Murakami; G H Sato
Journal:  In Vitro Cell Dev Biol       Date:  1990-01

Review 3.  The epidemiology and genetics of vitiligo.

Authors:  J J Nordlund
Journal:  Clin Dermatol       Date:  1997 Nov-Dec       Impact factor: 3.541

4.  Record of the first physician to see Henrietta Lacks at the Johns Hopkins Hospital: history of the beginning of the HeLa cell line.

Authors:  H W Jones
Journal:  Am J Obstet Gynecol       Date:  1997-06       Impact factor: 8.661

Review 5.  Vitiligo.

Authors:  S O Kovacs
Journal:  J Am Acad Dermatol       Date:  1998-05       Impact factor: 11.527

Review 6.  Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: disorders of protein trafficking and the role of ER molecular chaperones.

Authors:  P S Kim; P Arvan
Journal:  Endocr Rev       Date:  1998-04       Impact factor: 19.871

7.  In vitro growth characteristics of melanocytes obtained from adult normal and vitiligo subjects.

Authors:  N Puri; M Mojamdar; A Ramaiah
Journal:  J Invest Dermatol       Date:  1987-04       Impact factor: 8.551

8.  Pattern of familial aggregation of vitiligo.

Authors:  P P Majumder; J J Nordlund; S K Nath
Journal:  Arch Dermatol       Date:  1993-08

Review 9.  The role of human papillomaviruses in anogenital cancers.

Authors:  M Melbye; M Frisch
Journal:  Semin Cancer Biol       Date:  1998-08       Impact factor: 15.707

10.  On the analysis of the pathophysiology of Chediak-Higashi syndrome. Defects expressed by cultured melanocytes.

Authors:  H Zhao; Y L Boissy; Z Abdel-Malek; R A King; J J Nordlund; R E Boissy
Journal:  Lab Invest       Date:  1994-07       Impact factor: 5.662

View more
  11 in total

1.  Heme oxygenase-1 expression protects melanocytes from stress-induced cell death: implications for vitiligo.

Authors:  Yasser E Elassiuty; Jared Klarquist; Jodi Speiser; Randa M Yousef; Abdelaziz A El Refaee; Nahla S Hunter; Olfat G Shaker; Mohan Gundeti; Ludmila Nieuweboer-Krobotova; I Caroline Le Poole
Journal:  Exp Dermatol       Date:  2011-03-22       Impact factor: 3.960

2.  4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo.

Authors:  Tara M Kroll; Hemamalini Bommiasamy; Raymond E Boissy; Claudia Hernandez; Brian J Nickoloff; Ruben Mestril; I Caroline Le Poole
Journal:  J Invest Dermatol       Date:  2005-04       Impact factor: 8.551

3.  MicroRNA-211 Regulates Oxidative Phosphorylation and Energy Metabolism in Human Vitiligo.

Authors:  Anupama Sahoo; Bongyong Lee; Katia Boniface; Julien Seneschal; Sanjaya K Sahoo; Tatsuya Seki; Chunyan Wang; Soumen Das; Xianlin Han; Michael Steppie; Sudipta Seal; Alain Taieb; Ranjan J Perera
Journal:  J Invest Dermatol       Date:  2017-05-11       Impact factor: 8.551

4.  The nuclear factor (erythroid-derived 2)-like 2 (NRF2) antioxidant response promotes melanocyte viability and reduces toxicity of the vitiligo-inducing phenol monobenzone.

Authors:  Omotayo A Arowojolu; Seth J Orlow; Nada Elbuluk; Prashiela Manga
Journal:  Exp Dermatol       Date:  2017-07       Impact factor: 3.960

5.  'VIT1', a novel gene associated with vitiligo.

Authors:  I C Le Poole; R Sarangarajan; Y Zhao; L S Stennett; T L Brown; P Sheth; T Miki; R E Boissy
Journal:  Pigment Cell Res       Date:  2001-12

6.  A role for tyrosinase-related protein 1 in 4-tert-butylphenol-induced toxicity in melanocytes: Implications for vitiligo.

Authors:  Prashiela Manga; David Sheyn; Fan Yang; Rangaprasad Sarangarajan; Raymond E Boissy
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

7.  Immortalization of human melanocytes does not alter the de novo properties of nitric oxide to induce cell detachment from extracellular matrix components via cGMP.

Authors:  Krassimira Ivanova; Britta Lambers; Rene van den Wijngaard; I Caroline Le Poole; Olga Grigorieva; Rupert Gerzer; Pranab K Das
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-07-02       Impact factor: 2.416

8.  Differential expression of a cutaneous corticotropin-releasing hormone system.

Authors:  Andrzej Slominski; Alexander Pisarchik; Desmond J Tobin; Joseph E Mazurkiewicz; Jacobo Wortsman
Journal:  Endocrinology       Date:  2003-11-06       Impact factor: 4.736

9.  Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8.

Authors:  Siavash Toosi; Seth J Orlow; Prashiela Manga
Journal:  J Invest Dermatol       Date:  2012-06-14       Impact factor: 8.551

10.  Inactivation of the CRL4-CDT2-SET8/p21 ubiquitylation and degradation axis underlies the therapeutic efficacy of pevonedistat in melanoma.

Authors:  Mouadh Benamar; Fadila Guessous; Kangping Du; Patrick Corbett; Joseph Obeid; Daniel Gioeli; Craig L Slingluff; Tarek Abbas
Journal:  EBioMedicine       Date:  2016-06-16       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.